10X Genomics, Inc. (TXG)
72.39
-0.71
(-0.97%)
USD |
NASDAQ |
Oct 15, 16:00
72.83
+0.44
(+0.61%)
After-Hours: 05:23
10X Genomics Research and Development Expense (Quarterly) : 56.79M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 56.79M |
| March 31, 2026 | 56.85M |
| December 31, 2025 | 55.97M |
| September 30, 2025 | 57.19M |
| June 30, 2025 | 61.22M |
| March 31, 2025 | 64.24M |
| December 31, 2024 | 66.97M |
| September 30, 2024 | 66.17M |
| June 30, 2024 | 62.92M |
| March 31, 2024 | 67.94M |
| December 31, 2023 | 55.55M |
| September 30, 2023 | 57.14M |
| June 30, 2023 | 61.52M |
| March 31, 2023 | 60.62M |
| December 31, 2022 | 57.09M |
| September 30, 2022 | 61.13M |
| June 30, 2022 | 64.18M |
| March 31, 2022 | 64.08M |
| December 31, 2021 | 61.88M |
| Date | Value |
|---|---|
| September 30, 2021 | 48.89M |
| June 30, 2021 | 48.51M |
| March 31, 2021 | 41.88M |
| December 31, 2020 | 39.70M |
| September 30, 2020 | 30.14M |
| June 30, 2020 | 27.54M |
| March 31, 2020 | 25.99M |
| December 31, 2019 | 27.89M |
| September 30, 2019 | 22.21M |
| June 30, 2019 | 18.03M |
| March 31, 2019 | 14.96M |
| December 31, 2018 | 13.08M |
| September 30, 2018 | 11.08M |
| June 30, 2018 | 11.44M |
| March 31, 2018 | 11.93M |
| December 31, 2017 | 9.531M |
| September 30, 2017 | 8.077M |
| June 30, 2017 | 7.338M |
| March 31, 2017 | 7.218M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Twist Bioscience Corp. | 18.02M |
| Tempus AI, Inc. | 96.57M |
| Personalis, Inc. | 16.34M |
| Intellia Therapeutics, Inc. | 80.50M |
| Alamar Biosciences, Inc. (California) | 13.82M |